Alnylam Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Great. Good morning, everyone. My name is Jess Fye. I'm a senior biotech analyst at JPMorgan, and we're delighted to be continuing the 42nd Annual Healthcare Conference today with Alnylam. I'm joined by the company's CEO, Yvonne Greenstreet. She's going to give a presentation. And then afterwards, we're going to move into Q&A. If you want to ask a question in the room, someone will bring you a mic. If you want to submit a question over the portal, you can do that as well. But very happy to hear Alnylam today. So I'll turn it over to you.
Thank you, Jessica. It's a real pleasure to be here presenting on behalf of Alnylam in what we expect to be a milestone year for our company.
I'm Yvonne Greenstreet and I'm CEO of Alnylam, and I'm very pleased to be joined up here on stage by Pushkal Garg, our Chief Medical Officer; Jeff Poulton, our Chief Financial Officer; and Tolga Tanguler, our Chief Commercial.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
